Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (54 quarters reported)
$19.1B in Q2 2013 → $472M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| BT Beta Technologies Inc Com Shs Cl A | 95.1% | Unchanged | 20,310,407 | $449M |
| HH Hyliion Holdings Corp Common Stock | 4.9% | Unchanged | 5,500,000 | $22.9M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed October 22, 2026
No position changes this quarter.
quarter ended June 30, 2026 · filed July 23, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 01, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BT Beta Technologies Inc Com Shs Cl A | Trimmed | −2,552,467 | −$37.5M | 96.9% |
quarter ended December 31, 2025 · filed February 05, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BT Beta Technologies Inc Com Shs Cl A Added | New | +22,862,874 | +$645M | 98.5% |
quarter ended September 30, 2025 · filed October 24, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed July 23, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 01, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| GH Ge Healthcare Technologies I Common Stock | Exited | +0 | — | — |
quarter ended December 31, 2024 · filed February 11, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| GH Ge Healthcare Technologies I Common Stock | Trimmed | −13,281,302 | — | — |
Loading...
